Leading French business daily Les Echos publishes op-ed co-authored by 12 BSP signatories

On December 8, 2021, France’s leading business daily Les Echos published an op-ed co-authored by 12 of the Biotech Social Pact signatories.

They call for policymakers to both place biomedical innovation at the heart of France’s healthcare system and start a truly inclusive dialogue with pharmaceutical industry, involving not only its historical stakeholders, but also and above all emerging French and international biotech companies, now accounting for 70% of new innovative treatments.

Co-authors of the op-ed include André Choulika (Chairman & CEO of Cellectis), Marc Le Bozec (Fund Manager at Financière Arbevel), Georges Rawadi (Former CEO of Ysopia Bioscience), Thomas Ybert (CEO of DNA Script), Xavier Duportet (Co-founder & CEO of Eligo Bioscience), John Crowley (Chairman & CEO of Amicus Therapeutics), Daniel A. de Boer (CEO of ProQR Therapeutics), Paul Hastings (CEO of Nkarta Therapeutics), Jeremy Levin (Chairman & CEO of Ovid Therapeutics), John Maraganore (Former CEO of Alnylam Pharmaceuticals), Onno Van De Stolpe (CEO of Galapagos) and Tim Van Hauwermeiren (CEO of argenx).